Cambridge Cognition has released a 2021 trading update which shows the company had a strong year, with revenue for the period increasing 51% YoY and the order book growing 52% YoY. The company beat DCe's forecasts at the PAT level and was in-line on revenue and cash. The robust demand for virtual clinical trials, which increased due to the pandemic, is expected to continue into 2022. We have updated our forecasts, with EBITDA now higher at £0.5m (£0.3m) in 2021 and for 2022 at £0.5m (£0.4m), whi ....
27 Jan 2022
Price Data Robust trading update
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Price Data Robust trading update
Cambridge Cognition Holdings Plc (COG:LON) | 52.0 0 0.0% | Mkt Cap: 18.3m
- Published:
27 Jan 2022 -
Author:
Paul Richards | Brendan D'Souza -
Pages:
6
Cambridge Cognition has released a 2021 trading update which shows the company had a strong year, with revenue for the period increasing 51% YoY and the order book growing 52% YoY. The company beat DCe's forecasts at the PAT level and was in-line on revenue and cash. The robust demand for virtual clinical trials, which increased due to the pandemic, is expected to continue into 2022. We have updated our forecasts, with EBITDA now higher at £0.5m (£0.3m) in 2021 and for 2022 at £0.5m (£0.4m), whi ....